Abstract
Globally emerging antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and extended spectrum beta-lactamase (ESBL)-producing Escherichia coli present increasing challenges to community transmission of infection. Recently, New Delhi metallo-beta-lactamase-1 (NDM-1) was identified; this enzyme makes bacteria resistant to most beta-lactam antibiotics which are used to treat antibiotic-resistant bacterial infections.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
